Researchers have uncovered the pharmacodynamic properties of novel antifungal, F901318, taking it one step closer to testing in clinical trials
Browsing: Fungal > Aspergillosis
In this piece, Fabio Gsaller discusses the mechanisms underpinning antifungal resistance in A. fumigatus and his work on the use of 5-flucytosine as a therapeutic agent in managing aspergillosis.
In this interview, we speak to Cornelia Lass-Flörl from the Innsbruck Medical University (Austria) who has a special interest in the epidemiology, diagnosis, prevention and therapy of fungal infections.
Take a look at our infographic to find out more about the burden of some common fungal infections and assess why the facts and figures are so uncertain.
The use of biomarkers for the detection of fungal infections is of interest to complement histopathological and culture methods. Could chemically synthesized Galactofuranose antigens, reviewed in this paper, be used for the synthesis of artificial carbohydrate-based antigens and in diagnosis?
This review delves into new diagnostic Aspergillus spp. procedures, in addition, the authors look at intrinsic antifungal resistance and mechanisms of secondary resistance to triazoles in A. fumigatus.